DEPLOY
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 May 2022)
What this means for you
This application is over — abandoned 02 May 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88856403
- Mark type
- Stylized text
- Filed
- 01 Apr 2020
- Published for opposition
- 02 Feb 2021
- Abandoned
- 02 May 2022
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Chemical agents for scientific and research use, namely, for manipulating or modifying DNA
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutic vaccines for the treatment of cancer, immune system related diseases, and infectious disease; pharmaceutical preparations and therapeutic vaccines, namely, cellular preparations, T-cell preparations and DC (dendritic cell) for the treatment of cancer, immune system related diseases, and infectious disease
- Class 009 — Scientific and electric apparatus: Downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development
- Class 040 — Treatment of materials: Custom manufacturing of cellular preparations, T-cell preparations and DCs (dendritic cells)
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals; custom engineering of cellular preparations, T-cell preparations and DCs (dendritic cells); providing temporary use of online non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing temporary use of online non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; providing temporary use of online non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development
Owner
- Repertoire Immune Medicines, Inc., Cambridge, MA, US
- Repertoire Immune Medicines, Inc., Cambridge, MA, US
Prosecution history
- 02 May 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 May 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2021 — SOU EXTENSION 1 GRANTED
- 20 Sept 2021 — SOU EXTENSION 1 FILED
- 20 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 30 Mar 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Feb 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Feb 2021 — PUBLISHED FOR OPPOSITION
- 13 Jan 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Dec 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Dec 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Dec 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Dec 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Jun 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED